| FFIV |
Report |
Q3 FY26 Revenue |
BEAT |
pred ~$841M vs. cons ~$833M |
MEDIUM |
| FFIV |
Report |
Q3 FY26 Non-GAAP EPS |
BEAT |
pred ~$4.05 vs. cons ~$3.99 |
MEDIUM |
| FFIV |
Report |
Q3 FY26 Non-GAAP Gross Margin |
MISS |
pred ~79.3% vs. cons ~80.5% |
MEDIUM |
| FFIV |
Guide |
Q4 FY26 Revenue Guidance |
BETTER |
guide ~$865M vs. cons ~$857M (Q4 FY26) |
MEDIUM |
| FFIV |
Guide |
Q4 FY26 Non-GAAP EPS Guidance |
LOWER |
guide ~$3.95 vs. cons ~$4.15 (Q4 FY26) |
MEDIUM |
| FFIV |
Guide |
FY2027 Gross Margin Outlook Commentary |
LOWER |
guide ~78.5% vs. cons ~80.0% (FY2027, reflecting memory/component cost headwind trough) |
MEDIUM |
| FFIV |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
MEDIUM |
| FFIV |
Return |
5-day cumulative residual |
-3.5% (FOLLOW-THROUGH) |
Q3 headline revenue/EPS likely clear the elevated bar, but management is expected to reiterate that memory/component cost inflation hits 'full run rate' in Q4 and pressures FY27 gross margin (per analyst-day framing of a margin trough before recovering by FY29). With the stock up ~50%+ YTD and trading near average price targets, any confirmation of margin caution should trigger a negative initial reaction; as sell-side models get updated in the following days to reflect lower FY27 EPS off a still-solid revenue base, the downward estimate revisions (implicit cuts to out-period EPS) should extend rather than reverse the initial move, producing follow-through weakness over the next week rather than a snap-back. |
MEDIUM |